(Q33362114)

English

Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

Ricardo Hitt

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Antonio Jimeno

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jose María Millán

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daniel Castellano

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hernán Cortés-Funes

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

768-775

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

A phase II study of paclitaxel and cisplatin combination chemotherapy in recurrent or metastatic head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck: long-term results of a phase II trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

21 January 2018

Chemotherapy advances in head and neck oncology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Overview of combined modality therapies for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Head and neck cancer in 1994: a change in the standard of care

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of locally advanced head and neck cancer: historical and critical review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

The taxoids: paclitaxel and docetaxel

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel administered over 3 h followed by cisplatin in patients with advanced head and neck squamous cell carcinoma: a clinical phase I study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III comparison of high-dose paclitaxel + cisplatin + granulocyte colony-stimulating factor versus low-dose paclitaxel + cisplatin in advanced head and neck cancer: Eastern Cooperative Oncology Group Study E1393

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Theoretical concepts and the emerging role of taxanes in adjuvant therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

A two-stage design for choosing among several experimental treatments and a control in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20439

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.20439

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33362114&oldid=1977854948"